Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008547 |
XU_ID: | XU-586 |
ID: | TCMBANKHE008547/XU-586 |
植物拉丁名: |
|
功能与主治: | To clear heat and resolve toxin, relieve cough and calm asthma, dispel wind-damp./Common cold with fever, swelling pain in throat, lung heat cough asthma, heat impediment swelling and pain, swelling of sores. |
药用植物名: | 母菊 |
来源: | 甘肃省定西市岷县 |
药用部位: | flower or whole herb|全株 |
KUMST_ID1: | KMUST-BS-0599 |
KUMST_ID2: | KMUST-2024041200013-1 |
TCM_ID_id: | 2721 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000916 | n1,n5,n10,n14-tetrakis[3-(4-hydroxyphenyl)-2-propenoyl]-1,5,10,14-tetraazatetradecane | C46H50N4O8 | 786.9 g/mol | C1=CC(=CC=C1C=CC(=O)NCCCN(CCCCN(CCCNC(=O)C=CC2=CC=C(C=C2)O)C(=O)C=CC3=CC=C(C=C3)O)C(=O)C=CC4=CC=C(C=C4)O)O | |
| TCMBANKIN005966 | n1,n5,n10-tris[3-(4-hydroxyphenyl)-2-propeno-yl]-1,5,10,14-tetraazatetradecane | C37H44N4O6 | C1=CC(=CC=C1C=CC(=O)NCCCN(CCCCN(CCCN)C(=O)C=CC2=CC=C(C=C2)O)C(=O)C=CC3=CC=C(C=C3)O)O | ||
| TCMBANKIN016181 | Chrysosplenetin | 5-hydroxy-2-(4-hydroxy-3-methoxy-phenyl)-3,6,7-trimethoxy-chromen-4-one; 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-4-chromenone; 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxychromen-4-one; 4H-1-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-; chrysosplenetin; 5-hydroxy-2-(4-hydroxy-3-methoxy-phenyl)-3,6,7-trimethoxy-chromone; Quercetagetin 3,6,7,3'-tetramethyl ether; 4H-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-; Chrysosplenetin B; 603-56-5; 69234-29-3; C10030 | C19H18O8 | 374.34 | COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)O)OC)O |
| TCMBANKIN017427 | apiin | C26H28O14 | 564.49 | C1C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC=C(C=C5)O)O)CO)O)O)O)(CO)O | |
| TCMBANKIN021845 | 2-hexadecanol | C16H34O | 242.44 | CCCCCCCCCCCCCCC(C)O | |
| TCMBANKIN023105 | 2-caffeoyloxy-3-hydroxy-3-(3,4-dihydroxy-phenyl)propyl alcohol | C18H18O8 | |||
| TCMBANKIN026251 | matricin | C17H22O5 | 306.4 g/mol | CC1C2C(CC(=C3C=CC(C3C2OC1=O)(C)O)C)OC(=O)C | |
| TCMBANKIN041605 | Bisabolol oxide A | bisabolol oxide-a | 238.37 g/mol | ||
| TCMBANKIN047544 | β-Bisabolol | ||||
| TCMBANKIN058410 | Azulen | InChI=1/C10H8/c1-2-5-9-7-4-8-10(9)6-3-1/h1-8; 82R6M9MGLP; 275-51-4; AC1L1SM7; MFCD00003810; AZULENE, M.P. 99 C; ST5411971;azulene; ACMC-209gy0; Cyclopentacycloheptene; A97203_ALDRICH; FCH1115647; 37879_RIEDEL; ZINC1570209; CHEBI:31249; DB-047243; UNII-82R6M9MGLP; TR-012336; A0634; SC-47564; NSC 89248; Bicyclo(5.3.0)-deca-2,4,6,8,10-pentaene; Azulene (JAN); DTXSID2059770; AN-5880; CC-24235; Bicyclo(0.3.5)deca-1,3,5,7,9-pentaene; Bicyclo(5.3.0)-1,3,5,7,9-decapentaene; labotest-bb lt00007822; azulene radical cation; Azulene cation radical; C-30055; SR-01000944574-1; AKOS015840881; D09768; ANW-26230; LS-23565; CS-0006517; bicyclo(5.3.0)-deca-1,3,5,7,9-pentaene; SR-01000944574; CHEMBL3272628; EINECS 205-993-6; S14-1306; Bicyclo(5.3.0)decapentaene; MCULE-9439882903; Azulene, standard for GC, >=99.0% (GC); CUFNKYGDVFVPHO-UHFFFAOYSA-N; ST50411971; S14-2908; cyclopentacyclohepten; Azunamic; LS40101; Bicyclo[5.3.0]-1,5,7,9-decapentaene; A819116; J-016811; NSC-89248; Azusalen [as sodium sulfonate]; NSC89248; Azulene, analytical standard; C13392; SBB056611; PubChem6349; CTK1A3397; KB-47493; Bicyclo[5.3.0]-1,3,5,7,9-decapentaene; azulene; Bicyclo[5.3.0]decapentaene; CJ-24708; Azulekeep; 11650_FLUKA; Azulene, 99%; FT-0622537; API0001577; azulen; CL22917; AZULENE | C10H8 | 128.17 g/mol | C1=CC=C2C=CC=C2C=C1 |
| TCMBANKIN059811 | guaiazulene | C15H18 | 198.3 g/mol | CC1=C2C=CC(=C2C=C(C=C1)C(C)C)C | |
| TCMBANKIN060345 | matricarin | C17H20O5 | 304.34 g/mol | CC1C2C(CC(=C3C(C2OC1=O)C(=CC3=O)C)C)OC(=O)C | |
| TCMBANKIN060738 | 1,4-dimethyl-7-ethylazulene | C14H16 | 184.28 g/mol | CCC1=CC2=C(C=CC2=C(C=C1)C)C | |
| TCMBANKIN061477 | vitexicarpin | 4H-1-Benzopyran-4-one, 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-; Casticine; SCHEMBL382354; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-4H-1-benzopyran-4-one; MolPort-005-938-589; 3',5-Dihydroxy-3,4',6,7-tetramethoxyflavone; Quercetagetin 3,6,7,4'-tetramethyl ether; 3',5-dihydroxy-3,4',6,7-tetramethoxyflavone; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-4H-benzopyran-4-one, 9CI; ZINC6018556; Q-100515; PJQLSMYMOKWUJG-UHFFFAOYSA-N; 4H-1-Benzopyran-4-one,5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-; 3,6,7,4'-Tetra-O-methyl-5,3'-dihydroxyflavone; NP-001928; I07-0245; Casticin; V1552; Casticin, United States Pharmacopeia (USP) Reference Standard; casticin; AKOS015896773; CHEMBL452767; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxychromen-4-one; AC1NSSVS; 3,6,7,4'-tetramethylquercetagetin; FT-0688327; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-3,6,7-trimethoxy-chromen-4-one; Vitexicarpin; 3-,5-Dihydroxy-3,4-,6,7-tetramethoxyflavone; DTXSID80197326; CHEBI:69355; Casticin(Vitexicarpin); AK554014; AN-10374; Agnus castus fruit standardised dry extract, European Pharmacopoeia (EP) Reference Standard; 479-91-4; 753GT729OU; 479V914; Agnus castus fruit dry extract, European Pharmacopoeia (EP) Reference Standard; vitexicarpin ; AC-6085; Casticin, analytical standard; N1318; Agnus castus fruit standardised dry extract; LMPK12113010; Casticin, primary pharmaceutical reference standard; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-4H-chromen-4-one; UNII-753GT729OU;casticin;vitxicarpin | C19H18O8 | 374.34 g/mol | COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)O)OC)O |
| TCMBANKIN061517 | patuletin-7-o-β-d-glucopyranoside | C22H22O13 | COC1=C(C=C(C2=C1OC(=C(C2=O)OC3C(C(C(C(O3)CO)O)O)O)C4=CC(=C(C=C4)O)O)O)O | ||
| TCMBANKIN061589 | chrysosplenelin;Chrysosplenetin | 5-hydroxy-2-(4-hydroxy-3-methoxy-phenyl)-3,6,7-trimethoxy-chromen-4-one; 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-4-chromenone; 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxychromen-4-one; 4H-1-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-; chrysosplenetin; 5-hydroxy-2-(4-hydroxy-3-methoxy-phenyl)-3,6,7-trimethoxy-chromone; Quercetagetin 3,6,7,3'-tetramethyl ether; 4H-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-; Chrysosplenetin B; 603-56-5; 69234-29-3; C10030 | C19H18O8 | 374.34 | COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)O)OC)O |
| TCMBANKIN061663 | axillarin | 3',4',5,7-Tetrahydroxy-3,6-dimethoxyflavone; axillarin ; DTXSID80199840; NCGC00168986-01; C10021; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-; CHEBI:2941; DMQT; Axillarin; 3',4',5,7-tetrahydroxy-3,6-dimethoxy-flavone; MCULE-1507651933; MEGxp0_000118; CHEMBL487810; AC1NQYPJ; 5188-73-8; 3,6-Dimethoxy-5,7,3',4'-tetrahydroxyflavone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxychromen-4-one; BDBM50242286; 3,6-Dimethoxyquercetagetin; ACon1_000535; SCHEMBL1155670; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-4H-chromen-4-one; Quercetagetin 3,6-dimethyl ether; NCGC00168986-02!2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxychromen-4-one; NP-000321; LMPK12112990; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-4H-1-benzopyran-4-one;ACon1_000535; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-chromone; 5188-73-8; 3',4',5,7-Tetrahydroxy-3,6-dimethoxyflavone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxychromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-; Quercetagetin 3,6-dimethyl ether; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-4-chromenone; Axillarin; C10021; 3,6-Dimethoxyquercetagetin; MEGxp0_000118; DMQT | C17H14O8 | 346.3 g/mol | COC1=C(C2=C(C=C1O)OC(=C(C2=O)OC)C3=CC(=C(C=C3)O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab